Journal Home
Search for

Volume 49, Issue 2, Pages 119-122 (March 2010)


View previous. 9 of 35 View next.

Functional Outcome and Patient Satisfaction after Flexor Tenotomy for Plantar Ulcers of the Toes

Tim Schepers, MD, PhD1Corresponding Author Informationemail address, Heleen A. Berendsen, MD2, I. Hok Oei, MD3, Jan Koning, MD, PhD4

published online 05 February 2010.

Abstract 

Ulcers of the toes may cause a severe physical burden, especially in patients with diabetes, in whom they occur most frequently. Several treatments have been proposed for the underlying anatomical abnormalities, but they vary in effectiveness. We evaluated our results in using flexor tenotomy to treat ulcers with underlying flexible clawing of the toes. For 42 toes from 23 patients, 15 of whom were diabetic, all ulcers healed. The mean healing time was 4 weeks (range, 1-8 weeks), the mean follow-up was 11 months (range, 1-27 months), and one recurrence and one complication occurred. Postoperative American Orthopaedic Foot Ankle Society Midfoot scores were available for 15 patients: the mean was 77 (range, 43-100). The mean visual analogue scale (VAS) for patient satisfaction increased from 3.9 points (range, 0-10 points) preoperatively to 7.7 (range, 5-10 points) postoperatively. Flexor tenotomy is a simple treatment with low complications and recurrence rates and provides good-to-excellent functional outcomes in treating flexible clawing of the toes and the associated ulceration.

Level of Clinical Evidence4

1 Resident Surgeon, Department of Surgery, Reinier de Graaf Groep Delft, The Netherlands

2 Physiatrist, Department of Rehabilitation, Reinier de Graaf Groep Delft, The Netherlands

3 Vascular Surgeon, Department of Surgery, Reinier de Graaf Groep Delft, The Netherlands

4 Vascular Surgeon, Department of Surgery, Reinier de Graaf Groep Delft, The Netherlands

Corresponding Author InformationAddress correspondence to: T. Schepers, MD, Department of Surgery, Reinier de Graaf Groep Delft, PO Box 5011, 2600 GA Delft, The Netherlands.

 Financial Disclosure: None reported.

 Conflict of Interest: None reported.

PII: S1067-2516(09)00508-0

doi:10.1053/j.jfas.2009.12.001


View previous. 9 of 35 View next.